Besides, over the past decades, numerous dysregulated genes involved in NSCLC have been identified as the potential biomarkers for prognosis, such as Glypican 3 (GPC3), Claudin-3 (CLDN3) and astrocyte-elevated gene-1 (AEG-1) 14. This evidence concerns the gene GPC3 and non-small cell lung carcinoma.